Facts, anecdotes, and new horizons in the medical treatment of duodenal ulcers.
There continue to be marked differences of opinion regarding how to manage duodenal ulcer disease. Recent developments in medical management which appear of major importance include the development of antagonists of H2-receptors of histamine, the prostaglandins, and transendoscopic instrumentation. Intractability of duodenal ulcer continues to be an over-used category which disguises situations that are easily remedied. Until we have more long-term and complete evaluations of ulcer treatment, we will continue to base therapy on anecdotes and incomplete data.
D000863:Antacids / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000150:complications / Q000601:surgery / Q000628:therapy*; D005336:Fiber Optic Technology; D005773:Gastroscopy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000628:therapy; D012075:Remission, Spontaneous
D000863:Antacids; D006635:Histamine H2 Antagonists